Kilindi Iyi

Denver voters narrowly approved a measure to decriminalize psychedelic mushrooms for adults. The unprecedented vote comes after the Denver Psilocybin Mushroom Decriminalization Initiative gathered enough signatures for the question to be added to the election [More]

Kevin Matthews, the Campaign Director of Decriminalize Denver, is leading an initiative to decriminalize psychedelic mushrooms in Denver. Denver Elections announced Friday that the measure earned enough signatures to appear on the May 7 ballot. [More]

Subscribe to our channel http://bit.ly/AJSubscribe A former British government drugs adviser has warned that clinical trials to cure depression are being blocked by EU drug regulations. Professor David Nutt is calling for a change in [More]

The hallucinogenic drug psilocybin, the active ingredient in certain mushrooms, is being used to reduce anxiety and depression in cancer patients. In two studies, it reduced symptoms in 60 to 80 percent of the patients. [More]

This is the age of home deliveries, from groceries to furniture, everything is available at your doorstep. But now, the service has extended to recreational drugs like ‘magic mushrooms’ as well. CNN-News18 (formerly known as [More]

Voters in the Mile High City have decriminalized “magic mushrooms” by the slimmest of margins, making Denver the country’s first city to de-prioritize enforcement of the hallucinogen. “WE WON!!!!” announced Decriminalize Denver after city elections [More]

Voters in the Colorado capital passed a measure to decriminalize ‘magic mushrooms,’ a psychedelic drug that causes hallucinations.

Voters this week narrowly made Denver the first U.S. city to decriminalize psilocybin, the psychoactive ingredient in so-called magic mushrooms. Mark Haden, executive director of the Multidisciplinary Association for Psychedelic Studies, discusses the push to [More]

Time lapse cubensis

On Tuesday, voters in Colorado’s capital city approved the decriminalization of psychedelic mushrooms. Joe St. George explains what’s next.